VTLVital Therapies +20% on shareholder OK on merger Apr. 5, 2019 9:08 AM ET|About: Vital Therapies, Inc. (VTL)|By: Mamta Mayani, SA News Editor Vital Therapies' (NASDAQ:VTL) stockholders approved the proposals required to complete the business combination with Immunic AG.
Approximately 98.82% of the shares voted in favor of the Exchange Agreement proposal. The merger is expected to be consummated by mid-April.
Vital Therapies will change its name to Immunic, Inc. and shares will trade on Nasdaq under the symbol “IMUX”.
Shares are up 20% premarket.
Previously: Vital Therapies to acquire Immunic AG in all-stock deal (Jan. 7)